Thank you to the thousands who have signed up to T1DRA so far – we are so grateful.
If you are waiting for your kit, we are sending them out as quickly as we can and yours should arrive within the next few weeks.
What is the T1DRA study?
Type 1 diabetes is a serious, lifelong autoimmune condition affecting up to 400,000 people in the UK. It occurs when the immune system destroys insulin-producing cells in the pancreas, meaning people can no longer make their own insulin and their blood sugar levels become dangerously high.
- More than half of type 1 diabetes is diagnosed in adults but very little is known about how the condition develops.
- T1DRA Study is testing blood samples in UK general population adults aged 18-70 to assess their risk.
- T1DRA aims to find out how many adults in the UK are at increased risk of developing type 1 diabetes and to understand more about immune changes before symptoms appear.
- Adults identified in the study who have multiple risk markers will be offered access to information about the symptoms of type 1 diabetes, its management and clinical trials testing new type 1 therapies.
We encourage people from all backgrounds and ethnicities to take part in T1DRA so our findings can accurately represent the adult UK population.
Click here to check if you are eligible.